Acadian Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-156
Closed -$30K 2022
2019
Q4
$30K Sell
156
-112,739
-100% -$20.3M ﹤0.01% 1678
2019
Q3
$19M Sell
112,895
-23,098
-17% -$3.76M 0.08% 224
2019
Q2
$22.8M Buy
135,993
+29,285
+27% +$4.06M 0.11% 181
2019
Q1
$15.6M Sell
106,708
-24,074
-18% -$3.49M 0.07% 225
2018
Q4
$17.5M Buy
130,782
+119,901
+1,102% +$19.7M 0.09% 193
2018
Q3
$2.07M Buy
10,881
+1,727
+19% +$317K 0.01% 556
2018
Q2
$1.53M Buy
9,154
+8,941
+4,198% +$1.44M 0.01% 628
2018
Q1
$36K Buy
213
+10
+5% +$1.68K ﹤0.01% 1413
2017
Q4
$34K Sell
203
-60
-23% -$10.8K ﹤0.01% 1291
2017
Q3
$54K Buy
263
+38
+17% +$8.84K ﹤0.01% 1101
2017
Q2
$55K Sell
225
-1,577
-88% -$371K ﹤0.01% 1118
2017
Q1
$431K Buy
1,802
+1,467
+438% +$342K ﹤0.01% 930
2016
Q4
$70K Buy
+335
New +$69.4K ﹤0.01% 1141

Other funds holding AGN

Acadian Asset Management's AGN Position: Q1 2020 in Review

Acadian Asset Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 156 shares — an estimated $30K sold.

Acadian Asset Management first reported a position in AGN in Q4 2016 and held it in 13 quarters. The position peaked at $22.8M in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Acadian Asset Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Acadian Asset Management sold 156 Allergan plc shares in Q1 2020, an estimated $30K.
  • Acadian Asset Management first reported a position in Allergan plc in Q4 2016 and held it in 13 quarters.
  • Acadian Asset Management's Allergan plc position peaked at $22.8M in Q2 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Acadian Asset Management's 13F filing for Q1 2020, filed 11 May 2020.